NNM Securities

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1350.602.95 (+0.22 %)

PREV CLOSE ( ) 1347.65

OPEN PRICE ( ) 1343.45

BID PRICE (QTY) 1350.00 (11)

OFFER PRICE (QTY) 1350.60 (72)

VOLUME 23051

TODAY'S LOW / HIGH ( )1335.35 1357.95

52 WK LOW / HIGH ( )891.3 1519

NSE1351.754.45 (+0.33 %)

PREV CLOSE( ) 1347.30

OPEN PRICE ( ) 1347.00

BID PRICE (QTY) 1351.60 (8)

OFFER PRICE (QTY) 1351.75 (156)

VOLUME 674519

TODAY'S LOW / HIGH( ) 1335.00 1357.70

52 WK LOW / HIGH ( )896.3 1519

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935

Management Info

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email contactus@cipla.com

Website www.cipla.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg, MCX

NEWS

16Apr Cipla, Deep Industries and Bharti Airt
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

16Apr Cipla's arm signs agreement for acquis
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

16Apr Cipla informs about allotment of equit
In compliance with the provisions of Regulation 30 of SEBI (Listing Obli..

08Apr USFDA Inspection At Company'S Manufac
USFDA inspection at Company''s manufacturing facility in Patalganga, Mah..

05Apr USFDA concludes routine cGMP inspectio
United States Food and Drug Administration (USFDA) has concluded routine..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	11141.4	25134.7
Gross Profit	13807.6	34405.4
Operating Profit	15248.4	42493.7
Net Sales	43813.3	157906

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2605.00 (2.45%)	M.Cap (Rs. in Cr)1540.43
Solara Active Pharma (BSE) 528.10 (11.39%)	M.Cap (Rs. in Cr)1799.09
Concord Biotech (BSE) 1601.15 (1.43%)	M.Cap (Rs. in Cr)16539.30
Chandra Bhagat Pharm (BSE) 114.85 (12.58%)	M.Cap (Rs. in Cr)85.90
Windlas Biotech (BSE) 531.50 (2.43%)	M.Cap (Rs. in Cr)1098.27

Shareholding Pattern

	PROMOTERS	33.47%
	MUTUAL FUNDS/UTI	16.66%
	NON-INSTITUTION	16.53%
	FI/BANKS/INSURANCE	5.47%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pha...	12.04
Nippon India Nifty ...	12.03
ICICI Pru Nifty Hea...	10.55
Axis NIFTY Healthcare ETF	10.54
Aditya Birla SL Nif...	10.53
Mirae Asset Healthc...	9.62
Aditya Birla SL Pha...	8.31

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

CIPLA LTD.

Filing compliant on SCORES – Easy & quick